Bazsa, we just had a 100 day report in Feb...
"As reported in February 2018, overall survival in Cohort A at day 100 was 87.5 percent, while the Overall and Complete Response rates by day 100 were 100 percent and 50 percent"
(one died of other complications)
This double dose to test efficacy at 28 days has gone from 1 to 4.
Good luck to MSB, but I do think these cells are outblasting the masterblaster.
And do not need harvesting! major point of difference when commercializing.
Ann: Positive 28-day Clinical Trial Data in Cohort B, page-33
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $37.94M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 21.0¢ | $423 | 2.016K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41003 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10656 | 1 |
View Market Depth
| Last trade - 12.11pm 27/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |